LETTER
Mixed P/S Ligands Derived from Natural D-Sugars
2967
(7) (a) Molander, G.; Burke, J.; Carrol, P. J. J. Org. Chem. 2004,
69, 8062. (b) Mancheño, O. G.; Gomez Arrayas, R.;
Carretero, J. C. J. Am. Chem. Soc. 2004, 126, 456. (c) Yan,
Y. Y.; RajanBabu, T. V. Org. Lett. 2000, 2, 199.
(d) Albinati, A.; Pregosin, P. S.; Wick, K. Organometallics
1996, 15, 2419.
(8) Khiar, N.; Araújo, C. S.; Alvarez, E.; Fernández, I.
Tetrahedron Lett. 2003, 44, 3401.
(9) Khiar, N.; Araújo, C. S.; Suárez, B.; Álvarez, E.; Fernández,
I. Chem. Commun. 2004, 44, 714.
J
PC = 2.7 Hz), 128.2 (d, JPC = 7.0 Hz), 128.1 (d, JPC = 7.0
Hz), 109.7, 81.3 (d, JPC = 5.6 Hz), 77.8 (d, JPC = 18.8 Hz),
75.6 (d, JPC = 5.0 Hz), 73.8, 66.6, 63.5, 43.8, 31.3, 27.9,
26.3, 20.8 ppm. 31P NMR (121.4 MHz, CDCl3): d = 117.5
ppm.
Compound 15: 1H NMR (500 MHz, CDCl3): d = 7.56–7.47
(m, 4 H), 7.34–7.29 (m, 6 H), 4.51 (d, 1 H, J = 9.5 Hz), 4.33–
4.26 (m, 3 H), 4.15 (dd, 1 H, J = 1.8, 5.6 Hz), 3.96–3.88 (m,
2 H), 2.03 (s, 3 H), 1.42 (s, 3 H), 1.29 (s, 3 H), 1.22 (s, 9 H)
ppm.13C NMR (125 MHz, CDCl3): d = 170.8, 142.9 (d,
JPC = 18.4 Hz), 142.1 (d, JPC = 15.2 Hz), 131.3 (d, JPC = 22.1
Hz), 130.5 (d, JPC = 21.3 Hz), 129.0 (d, JPC = 32.5 Hz), 128.0
(d, JPC = 6.4 Hz), 127.9 (d, JPC = 7.2 Hz), 110.5, 83.1 (d,
(10) (a) Ferrier, R. J.; Furneaux, R. H. Methods Carbohydr.
Chem. 1980, 8, 251. (b) Khiar, N.; Martin-Lomas, M. J.
Org. Chem. 1995, 60, 7017.
(11) Ishihara, K.; Kurihara, H.; Yamamoto, H. J. Org. Chem.
1993, 58, 3791.
(12) Yonehara, K.; Hashizume, T.; Mori, K.; Ohe, K.; Uemura, S.
J. Org. Chem. 1999, 64, 5593.
JPC = 3.3 Hz), 80.6 (d, JPC = 18.7 Hz), 79.3 (d, JPC = 2.7 Hz),
73.6 (2 C), 63.9, 44.1, 31.3, 27.7, 26.4, 20.8 ppm. 31P NMR
(121.4 MHz, CDCl3): d = 119.8 ppm.
Compound 21: 1H NMR (500 MHz, CDCl3): d = 7.54–7.46
(m, 4 H), 7.33–7.29 (m, 6 H), 4.76 (d, 1 H, J = 6.9 Hz), 4.28–
4.26 (m, 1 H), 4.22 (t, 1 H, J = 5.7 Hz), 4.10–4.01 (m, 1 H),
3.70 (dd, 1 H, J = 4.4, 12.7 Hz), 1.47 (s, 3 H), 1.30 (s, 3 H),
1.19 (s, 9 H) ppm.13C NMR (125 MHz, CDCl3): d = 131.2
(13) Compound 12: 1H NMR (500 MHz, CDCl3): d = 7.60–7.50
(m, 4 H), 7.38 –7.31 (m, 6 H), 7.21 (d, 2 H, J = 7.9 Hz), 7.02
(d, 2 H, J = 8.0 Hz), 4.58 (d, 1 H, J = 10.0 Hz), 4.35 (dd, 1
H, J = 4.5, 11.7 Hz), 4.29 (dd, 1 H, J = 7.7, 11.7 Hz), 4.23 (t,
1 H, J = 5.9 Hz), 4.13 (d, 1 H, J = 5.5 Hz), 4.02–3.93 (m, 2
H), 2.30 (s, 3 H), 1.43 (s, 3 H), 1.29 (s, 3 H), 1.19 (s, 9 H)
ppm. 13C NMR (125 MHz, CDCl3): d = 178.3, 137.7, 132.4,
131.1 (d, JPC = 11.8 Hz), 130.7 (d, JPC = 11.8 Hz), 129.3 (d,
(d, JPC = 22.1 Hz), 130.5 (d, JPC = 21.4 Hz), 129.1 (d, JPC
31.7 Hz), 128.1 (d, JPC = 5.9 Hz), 128.0 (d, JPC = 6.7 Hz),
=
110.1, 84.5, 82.6 (d, JPC = 4.2 Hz), 80.3 (d, JPC = 19.2 Hz),
72.2, 63.2, 44.0, 31.3, 27.8, 26.3 ppm. 31P NMR (121.4
MHz, CDCl3): d = 118.6 ppm.
J
J
PC = 26.0 Hz), 128.1 (d, JPC = 6.8 Hz), 110.5, 88.4 (d,
PC = 4.1 Hz), 80.4 (d, JPC = 28.4 Hz), 79.1, 74.0, 73.7, 63.7,
(14) Typical Procedure.
38.7, 27.8, 27.1, 26.4, 21.2 ppm. 31P NMR (121.4 MHz,
CDCl3): d = 119.5 ppm.
To a solution of the ligand (4.3 mol%) in dry deoxygenated
CH2Cl2 (0.5 mL), [PdCl(C3H5)]2 (1.5 mol%) was added
under argon. The reaction mixture was stirred for 1 h at r.t.,
then a catalytic amount of KOAc (0.5 mg) was added,
followed by BSA (3 mol equiv) and a solution of 1,3-
diphenyl-2-propenyl acetate (16, 1 mol equiv) in dry
deoxygenated CH2Cl2 (0.7 mL). The temperature was then
adjusted to the desired one (see Table 1) and dimethyl
malonate (3 equiv) was added. Once the reaction finished as
judged by TLC, the solvent was evaporated and the residue
purified by column chromatography, affording the desired
product 17 as a viscous oil, which solidify on standing. The
ee was determined by chiral HPLC using a Chiralpack AD
column (1 mL/min, i-PrOH–hexane, 5:95, 30 °C). Retention
times: (R)-17: tR = 14.2 min, (S)-17: tR = 19.5 min.
(15) (a) Selke, R. React. Kinet. Catal. Lett. 1980, 14, 463.
(b) Selke, R. J. Organomet. Chem. 1989, 370, 249.
(16) Kunz, H.; Pfrengle, W.; Sager, W. Tetrahedron Lett. 1989,
30, 4109.
Compound 13: 1H NMR (500 MHz, CDCl3): d = 7.58–7.49
(m, 4 H), 7.36–7.32 (m, 6 H), 7.23 (d, 2 H, J = 7.9 Hz), 7.03
(d, 2 H, J = 7.9 Hz), 4.56 (d, 1 H, J = 9.4 Hz), 4.33 (d, 2 H,
J = 6.1 Hz), 4.23 (t, 1 H, J = 5.9 Hz), 4.13 (dd, 1 H,
J = 5.5, 1.5 Hz), 4.03–3.91 (m, 2 H), 2.31 (s, 3 H), 2.07 (s, 3
H), 1.41 (s, 3 H), 1.28 (s, 3 H) ppm. 13C NMR (125 MHz,
CDCl3): d = 170.8, 142.6 (d, JPC = 18.5 Hz), 141.9 (d,
JPC = 15.4 Hz), 137.7, 132.6, 130.9 (d, JPC = 21.8 Hz), 130.8
(d, JPC = 21.8 Hz), 130.2, 129.3 (d, JPC = 30.2 Hz), 128.1 (d,
JPC = 6.9 Hz), 110.6, 87.9 (d, JPC = 4.2 Hz), 80.0 (d,
JPC = 18.4 Hz), 79.1, 73.9, 73.6, 63.8, 27.7, 26.4, 21.1, 20.8
ppm. 31P NMR (121.4 MHz, CDCl3): d = 119.4 ppm.
Compound 14: 1H NMR (500 MHz, CDCl3): d = 7.57–7.50
(m, 4 H), 7.35–7.32 (m, 6 H), 5.56 (d, 1 H, J = 5.1 Hz), 4.70–
4.67 (m, 1 H), 4.34–4.11 (m, 5 H), 2.02 (s, 3 H), 1.41 (s, 3
H), 1.30 (s, 12 H) ppm. 13C NMR (125 MHz, CDCl3): d =
170.7, 141.8 (d, JPC = 19.4 Hz), 141.7 (d, JPC = 16.0 Hz),
130.9 (d, JPC = 21.8 Hz), 130.7 (d, JPC = 21.7 Hz), 129.3 (d,
Synlett 2005, No. 19, 2963–2967 © Thieme Stuttgart · New York